Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Feb 2025 – 20 Aug 2026, limited by Bajaj Finserv ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bajaj Finserv ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 03 Feb 2025 | ₹100.00 | ₹100.00 |
| 22 Mar 2025 | ₹103.99 | ₹99.40 |
| 08 May 2025 | ₹106.59 | ₹102.06 |
| 24 Jun 2025 | ₹111.50 | ₹107.99 |
| 10 Aug 2025 | ₹107.60 | ₹104.86 |
| 26 Sep 2025 | ₹109.17 | ₹106.12 |
| 12 Nov 2025 | ₹114.84 | ₹111.37 |
| 28 Dec 2025 | ₹113.63 | ₹111.11 |
| 13 Feb 2026 | ₹111.92 | ₹108.93 |
| 01 Apr 2026 | ₹101.59 | ₹97.82 |
| 18 May 2026 | ₹111.35 | ₹104.95 |
| 04 Jul 2026 | ₹116.02 | ₹108.87 |
| 20 Aug 2026 | ₹116.52 | ₹109.86 |
| Metric | Bajaj Finserv · Regular · IDCW NAV ₹11.69 Very High risk ★★★★☆ 1Y | Category median ELSS · 66 funds |
|---|---|---|
| +5.22% | +1.19% | |
| — | +8.64% | |
| — | +7.82% | |
| — | +9.60% | |
| +10.43% | +8.99% | |
| +7.35% | — | |
| — | +10.48% | |
| — | +10.98% | |
| — | +8.21% | |
| Risk | ||
| 13.20% | 14.15% | |
| -0.10 | 0.21 | |
| -0.14 | 0.29 | |
| -14.08% | -39.29% | |
| Nifty 500 | — | |
| — | -2.44% | |
| — | 0.95 | |
| — | 85.5% | |
| — | 95.8% | |
| 2.99% | 2.37% | |
| ₹82.41Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 138% | 34% | |
| Siddharth Chaudhary | — | |
| 03 Feb 2025 | — | |
| 49 | — | |
| 43.1% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.